secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0000950170-22-024697
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics posts updated corporate presentation to website on November 14, 2022
--------------------------------------------------------------------------------

- Updated corporate presentation posted on November 14, 2022 under 'Events & Presentations' section of Finch's website.
- Presentation covers general business update and microbiome pipeline; no specific financial or clinical data disclosed.
- No earnings, guidance, or material operational milestones announced in this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000095017022024697/0000950170-22-024697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000095017022024697/fnch-20221114.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-024697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer